FDA Slams Chinese OTC Maker for Serious Quality Violations

Drug Industry Daily
A A
The FDA hit Hangzhou SunKing Nonwovens with a warning letter, citing the manufacturer for numerous quality violations at its Hangzhou, Zhejiang facility.

To View This Article:

Login

Subscribe To Drug Industry Daily